TGTimothy P. Gavin

Timothy P. Gavin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Timothy P. Gavin has a total of 97 co-authors. Here are the top co-authors by number of shared publications:

  • Shihuan Kuang

    Department of Orthopaedic Surgery Duke University Durham North Carolina USA

    10 shared publications
  • Yaohui Nie

    Department of Health and Kinesiology, Max E. Wastl Human Performance Laboratory, Purdue University, West Lafayette, USA

    10 shared publications
  • Brian P. Sullivan

    Department of Health and Kinesiology, Max E. Wastl Human Performance Laboratory, Purdue University, West Lafayette, USA

    6 shared publications
  • Christopher K. Kargl

    Department of Health and Kinesiology, Max E. Wastl Human Performance Laboratory, Purdue University, West Lafayette, USA

    5 shared publications
  • Julianne Stout

    Department of Pediatrics Indiana University School of Medicine–West Lafayette West Lafayette Indiana USA

    5 shared publications
  • Shihuan Kuang

    Duke University School of Medicine

    5 shared publications

Latest Publications

  • Open Access

    Impact of obesity and an obesogenic environment on cardiotoxin‐induced damage and recovery of human myotubes

    by Brian P. Sullivan, Lundon C. Burton, Allison Ellis, Christopher K. Kargl, Deborah Shera, Shihuan Kuang, James F. Markworth, Timothy P. Gavin

    Obesity (BMI ≥ 30 kg/m 2 ) reduces skeletal muscle quality and impairs the myogenic response to muscle damage. The present study investigated if differences exist in myotubes from individuals with (OB) or without (LN) obesity incubated in control (bovine serum albumin [BSA]) or obesogenic (Ob) medium, at baseline or in response to cardiotoxin (CTX)‐induced damage and recovery. Differentiated, primary human myotubes from LN and OB donors were cultured in control (BSA‐DM) or (Ob‐DM) (250 µM palmitate, 250 µM oleate, 100 nM insulin, and 2.5 ng/mL tumour necrosis factor) differentiation medium (DM) for 48 h and treated with 1.0 µM CTX or vehicle control for 1 h (immediately post [IP]). Myotubes recovered in Ob (Ob‐GM) or BSA (BSA‐GM) growth medium (GM) for 3 days (3D). At baseline, myotubes (LN and OB) incubated in Ob‐DM had 5% lower fusion index (FI) and nuclei/tube than BSA‐DM. At IP post‐CTX, there were no differences in FI or membrane integrity (lactate dehydrogenase), but the reduction in cell viability was greater in OB than LN myotubes and greater in myotubes (LN and OB) incubated in Ob‐DM than BSA‐DM. At 3D post‐CTX, total nuclei, FI, and nuclei/tube were ∼15% lower in myotubes (LN and OB) incubated in Ob‐GM than BSA‐GM. Expressed as recovery (3D‐IP) post‐CTX, Ob‐GM lowered total nuclei and FI in myotubes without differences between LN and OB. In human myotubes, impaired formation and recovery following damage in obesity appear primarily due to the obesogenic environment rather than inherent, individual differences.

  • Open Access

    Noradrenergic regulation of skeletal muscle oxygen pressures: Impact of heart failure with preserved ejection fraction and heat therapy

    by Edward T. N. Calvo, Jacob M. Pontorno, Benjamin Zeidler, Taciane M. M. Pejon, Michael D. Belbis, Scott K. Ferguson, Craig J. Goergen, Timothy P. Gavin, Bruno T. Roseguini, Igor A. Fernandes, et al.

    Attenuation of sympathetic vasoconstriction during exercise (functional sympatholysis) contributes to skeletal muscle oxygen delivery–utilization matching. However, the extent to which muscle contractions impact noradrenergic regulation of interstitial oxygen pressures (; the driving force for blood–myocyte oxygen flux) is unknown. We tested the hypotheses that (1) muscle contractions would attenuate the noradrenaline‐induced reduction in muscle compared to rest (thus indicating functional sympatholysis) in healthy rats, and (2) functional sympatholysis would be impaired in rats with heart failure with preserved ejection fraction (HFpEF) but ameliorated with heat therapy. Skeletal muscle was determined via phosphorescence quenching in anaesthetized healthy (Sprague–Dawley, n = 14) and HFpEF rats (obese ZSF1, n = 20) at rest and during contractions following noradrenaline superfusion (5 × 10 −4  M). HFpEF rats underwent 8 weeks of heat therapy (HEAT, n = 10) or control treatment (CON; n = 10). Functional sympatholysis was evaluated based on the noradrenaline‐induced changes in at rest and during contractions normalized to mean arterial pressure (Δ/MAP; %/mmHg). Consistent with our hypothesis, muscle contractions attenuated the noradrenaline‐evoked reductions in healthy rats (rest: −0.50 ± 0.23, contractions: −0.25 ± 0.16; P  < 0.05). Compared to healthy rats, the noradrenergic response at rest was exacerbated in HFpEF‐CON (−0.85 ± 0.13; P  < 0.05) but restored in HFpEF‐HEAT (−0.61 ± 0.25; P  > 0.05). During contractions, the noradrenergic response was not different between HFpEF‐CON and HFpEF‐HEAT (−0.94 ± 0.07 and −0.86 ± 0.09, respectively; P  > 0.05). Moreover, the magnitude of sympatholysis was lower in both HFpEF‐CON and HFpEF‐HEAT compared to healthy. Taken together, these results indicate that heat therapy failed to improve functional sympatholysis in HFpEF rats but restored the noradrenergic response in resting skeletal muscle.


  • Effects of heat therapy on exercise tolerance in a rat model of heart failure with preserved ejection fraction

    by Michael D. Belbis, Bohyun Ro, Luke E. Schepers, Kun Ho Kim, Zhen Yap, Taylor A. Schultz, Mckayla D. Tallman, Morgan F. Killam, Sara E. Hobart, Oluwapamimo J. Fafowora, et al.

    This is the first evaluation of the effects of heat therapy (HT) in heart failure with preserved ejection fraction (HFpEF). HT elicited multiple central and peripheral adaptations that impacted positively exercise tolerance in a preclinical model of HFpEF. HT adaptations included improvements in cardiac function, body composition, and skeletal muscle oxygenation (mediated partially via enhanced nitric oxide bioavailability). These novel findings indicate that HT may hold important clinical significance for the treatment of HFpEF.


  • Open Access

    Effects of acute selective cyclooxygenase‐2 inhibition on skeletal muscle microvascular oxygenation and exercise tolerance

    by Michael D. Belbis, Michael J. Holmes, Joseph Yao, Christopher W. Kinnick, Christopher K. Kargl, Carly Day, Nicole L. Noel, Timothy P. Gavin, Bruno T. Roseguini, Daniel M. Hirai

    The cyclooxygenase (COX) pathway regulates vascular tone and, therefore, local O 2 delivery‐utilization matching. The two main isoforms, COX‐1 and COX‐2, may promote opposing effects on contracting muscle O 2 transport in health by inducing vasoconstriction and vasodilatation, respectively. Whether COX‐2 and its main vasodilatory product (prostacyclin, PGI 2 ) modulate microvascular O 2 transport to skeletal muscle and thus exercise tolerance is unknown. We tested the hypothesis that acute selective COX‐2 inhibition (SC2I) would impair cardiorespiratory and skeletal muscle microvascular responses from rest to exercise, thereby reducing exercise tolerance in healthy adults. Twelve individuals participated in a randomized, double‐blind, crossover study to receive SC2I (200 mg celecoxib) or placebo (control, CON). Moderate and severe intensity cycling were performed with measurements of heart rate, arterial blood pressure, pulmonary oxygen uptake (), leg muscle microvascular oxygenation (; near‐infrared spectroscopy) and time to exhaustion. Leg muscle was also assessed during cuff occlusion protocols. SC2I decreased the plasma concentration of the stable PGI 2 metabolite 6‐keto prostaglandin F 1α (CON: 203 (54) pg/mL; SC2I: 108 (54) pg/mL; P = 0.002). There was no difference in exercise tolerance (CON: 278 (55) s; SC2I: 298 (75) s), arterial blood pressure, heart rate, pulmonary or leg muscle from rest to moderate or severe exercise between conditions ( P  > 0.05 for all). Moreover, there was no significant difference in during cuff occlusion protocols between conditions. Contrary to our hypothesis, these data indicate that COX‐2 is not obligatory for the regulation of skeletal muscle microvascular oxygenation at rest or during moderate or severe intensity exercise, and therefore does not modulate exercise tolerance in healthy adults.

  • Open Access

    Angiogenic potential of skeletal muscle derived extracellular vesicles differs between oxidative and glycolytic muscle tissue in mice

    by Christopher K. Kargl, Zhihao Jia, Deborah A. Shera, Brian P. Sullivan, Lundon C. Burton, Kun Ho Kim, Yaohui Nie, Monica J. Hubal, Jonathan H. Shannahan, Shihuan Kuang, et al.

    Skeletal muscle fibers regulate surrounding endothelial cells (EC) via secretion of numerous angiogenic factors, including extracellular vesicles (SkM-EV). Muscle fibers are broadly classified as oxidative (OXI) or glycolytic (GLY) depending on their metabolic characteristics. OXI fibers secrete more pro-angiogenic factors and have greater capillary densities than GLY fibers. OXI muscle secretes more EV than GLY, however it is unknown whether muscle metabolic characteristics regulate EV contents and signaling potential. EVs were isolated from primarily oxidative or glycolytic muscle tissue from mice. MicroRNA (miR) contents were determined and endothelial cells were treated with OXI- and GLY-EV to investigate angiogenic signaling potential. There were considerable differences in miR contents between OXI- and GLY-EV and pathway analysis identified that OXI-EV miR were predicted to positively regulate multiple endothelial-specific pathways, compared to GLY-EV. OXI-EV improved in vitro angiogenesis, which may have been mediated through nitric oxide synthase (NOS) related pathways, as treatment of endothelial cells with a non-selective NOS inhibitor abolished the angiogenic benefits of OXI-EV. This is the first report to show widespread differences in miR contents between SkM-EV isolated from metabolically different muscle tissue and the first to demonstrate that oxidative muscle tissue secretes EV with greater angiogenic signaling potential than glycolytic muscle tissue.


  • Effects of heat therapy on skeletal muscle interstitial oxygenation and exercise tolerance in HFpEF rats

    by Michael Belbis, Bohyun Ro, Luke Schepers, Kun Kim, Kyoungrae Kim, Terence Ryan, Craig Goergen, Shihuan Kuang, Timothy Gavin, Bruno Roseguini, et al.

    Heart failure with preserved ejection fraction (HFpEF) impairs skeletal muscle microvascular function and blood flow thereby reducing exercise tolerance. Limited therapies currently exist to restore physical capacity in HFpEF. Heat therapy has been shown to improve cardiovascular outcomes and exercise tolerance in health and other diseases. PURPOSE: To test the hypothesis that chronic whole-body heat therapy would improve heart function and morphology, body composition, skeletal muscle interstitial oxygenation (PO2) and, therefore, exercise tolerance in a rodent model of HFpEF. METHODS: Male obese ZSF1 rats (5-6 mo) underwent either 8 weeks (6 days/wk) of heat therapy (HT; 39°C; n=10) or control (CON; 22°C; n=8) interventions. Exercise tolerance (treadmill tests to exhaustion), body composition (echoMRI) and heart function and morphology (echocardiography) were assessed pre- and post-intervention. Spinotrapezius PO2 (phosphorescence quenching) was assessed post-intervention from rest to submaximal contractions (1 Hz, 5-7 V, 3 min). RESULTS: Repeated HT prevented the decline in the main outcome of exercise tolerance (PRE:424±17, POST:425±13 s; p>0.05) observed in CON (PRE:444±24, POST:319±24 s; p0.05). There were no differences in isovolumetric relaxation time after treatment (CON PRE:23±2, POST:24±1; HT PRE:21±1, POST:24±2 ms; p>0.05). HT averted the decline in left ventricular ejection fraction (PRE:71.3±1.7, POST:73.7±2.3 %; p>0.05) observed in CON (PRE:75.3±0.9, POST:67.9±4.0 %; p<0.05). Total body mass increased in both groups during the 8 wk intervention period (CON PRE:564±8, POST:647±12; HT PRE:550±17, POST:631±18 g; p0.05), it was reduced after HT (PRE:0.38±0.01; POST:0.35±0.01 g/mg; p0.05) but was increased after HT (PRE:0.56±0.01, POST:0.60±0.01 g/mg; p<0.05). In addition, HT elevated the resting spinotrapezius PO2 (CON:15.9±1.4, HT:19.1±1.0 mmHg; p<0.05) and improved (slowed) the overall speed of PO2 fall during muscle contractions (T63; CON:18±2, HT:23±1 s; p<0.05). CONCLUSIONS: Repeated HT preserves left ventricular ejection fraction and exercise tolerance whilst improving body composition in rats with HFpEF. Moreover, HT enhances skeletal muscle interstitial PO2 from rest to submaximal contractions. Chronic whole-body HT promotes central and peripheral adaptations that impact positively exercise tolerance in a pre-clinical model of HFpEF. ACSM Doctoral Student Research Grant and Purdue University. This is the full abstract presented at the American Physiology Summit 2023 meeting and is only available in HTML format. There are no additional versions or additional content available for this Physiology was not involved in the peer review process.

  • Top Cited Papers
    Open Access

    Exercise-induced skeletal muscle angiogenesis: impact of age, sex, angiocrines and cellular mediators

    by Mark Ross, Christopher K. Kargl, Richard Ferguson, Timothy P. Gavin, Ylva Hellsten

    Exercise-induced skeletal muscle angiogenesis is a well-known physiological adaptation that occurs in humans in response to exercise training and can lead to endurance performance benefits, as well as improvements in cardiovascular and skeletal tissue health. An increase in capillary density in skeletal muscle improves diffusive oxygen exchange and waste extraction, and thus greater fatigue resistance, which has application to athletes but also to the general population. Exercise-induced angiogenesis can significantly contribute to improvements in cardiovascular and metabolic health, such as the increase in muscle glucose uptake, important for the prevention of diabetes. Recently, our understanding of the mechanisms by which angiogenesis occurs with exercise has grown substantially. This review will detail the biochemical, cellular and biomechanical signals for exercise-induced skeletal muscle angiogenesis, including recent work on extracellular vesicles and circulating angiogenic cells. In addition, the influence of age, sex, exercise intensity/duration, as well as recent observations with the use of blood flow restricted exercise, will also be discussed in detail. This review will provide academics and practitioners with mechanistic and applied evidence for optimising training interventions to promote physical performance through manipulating capillarisation in skeletal muscle.


  • Open Access

    Peroxisome proliferator‐activated receptor γ coactivator 1‐α overexpression improves angiogenic signalling potential of skeletal muscle‐derived extracellular vesicles

    by Chris K. Kargl, Brian P. Sullivan, Derek Middleton, Andrew York, Lundon C. Burton, Jeffrey J. Brault, Shihuan Kuang, Timothy P. Gavin

    Skeletal muscle capillarization is proportional to muscle fibre mitochondrial content and oxidative capacity. Skeletal muscle cells secrete many factors that regulate neighbouring capillary endothelial cells (ECs), including extracellular vesicles (SkM‐EVs). Peroxisome proliferator‐activated receptor γ coactivator 1‐α (PGC‐1α) regulates mitochondrial biogenesis and the oxidative phenotype in skeletal muscle. Skeletal muscle PGC‐1α also regulates secretion of multiple angiogenic factors, but it is unknown whether PGC‐1α regulates SkM‐EV release, contents and angiogenic signalling potential. PGC‐1α was overexpressed via adenovirus in primary human myotubes. EVs were collected from PGC‐1α‐overexpressing myotubes (PGC‐EVs) as well as from green fluorescent protein‐overexpressing myotubes (GFP‐EVs), and from untreated myotubes. EV release and select mRNA contents were measured from EVs. Additionally, ECs were treated with EVs to measure angiogenic potential of EVs in normal conditions and following an oxidative stress challenge. PGC‐1α overexpression did not impact EV release but did elevate EV content of mRNAs for several antioxidant proteins (nuclear factor erythroid 2‐related factor 2, superoxide dismutase 2, glutathione peroxidase). PGC‐EV treatment of cultured human umbilical vein endothelial cells (HUVECs) increased their proliferation (+36.6%), tube formation (length: +28.1%; number: +25.7%) and cellular viability (+52.9%), and reduced reactive oxygen species levels (−41%) compared to GFP‐EVs. Additionally, PGC‐EV treatment protected against tube formation impairments and induction of cellular senescence following acute oxidative stress. Overexpression of PGC‐1α in human myotubes increases the angiogenic potential of SkM‐EVs. These angiogenic benefits coincided with increased anti‐oxidative capacity of recipient HUVECs. High PGC‐1α expression in skeletal muscle may prompt the release of SkM‐EVs that support vascular redox homeostasis and angiogenesis.


  • Effects of obesity and acute resistance exercise on skeletal muscle angiogenic communication pathways

    by Ron T. Garner, Jessica A. Weiss, Yaohui Nie, Brian P. Sullivan, Christopher K. Kargl, Cathal J. Drohan, Shihuan Kuang, Julianne Stout, Timothy P. Gavin

    New Findings: What is the central question of this study? Do obesity and acute resistance exercise alter the regulation of muscle intercellular communication pathways consistent with inadequate compensatory angiogenesis in response to muscle loading present in individuals with obesity? What is the main finding and its importance? Obesity is associated with differences in both pro‐ and anti‐angiogenic signalling consistent with lower muscle capillarization. Acute resistance exercise increases the release of skeletal muscle small extracellular vesicles independent of body mass. These results identify new cellular factors associated with impaired angiogenesis in obesity and the positive effects of acute resistance exercise in lean and obese skeletal muscle. Obesity (OB) impairs cell‐to‐cell communication signalling. Small extracellular vesicles (EVs), which include exosomes, are released by skeletal muscle and participate in cell‐to‐cell communication, including the regulation of angiogenesis. Resistance exercise (REx) increases muscle fibre size and capillarization. Although obesity increases muscle fibre size, there is an inadequate increase in capillarization such that capillary density is reduced. It was hypothesized that REx‐induced angiogenic signalling and EV biogenesis would be lower with obesity. Sedentary lean (LN) and OB subjects (n = 8 per group) performed three sets of single‐leg knee‐extension REx at 80% of maximum. Muscle biopsies were obtained at rest, 15 min and 3 h postexercise and analysed for angiogenic and EV biogenesis mRNA and protein. In OB subjects, muscle fibre size was ∼20% greater and capillary density with type II fibres ∼25% lower compared with LN subjects (P < 0.001). In response to REx, the increase in VEGF mRNA (pro‐angiogenic) was similar (3‐fold) between groups, while thrombospondin‐1 (TSP‐1) mRNA (anti‐angiogenic) increased ∼2.5‐fold in OB subjects only (P = 0.010). miR‐130a (pro‐angiogenic) was ∼1.4‐fold (P = 0.011) and miR‐503 (anti‐angiogenic) ∼1.8‐fold (P = 0.017) greater in OB compared with LN subjects at all time points. In both groups, acute REx decreased the EV surface protein Alix by ∼50%, consistent with the release of exosomes (P = 0.016). Acute REx appears to induce the release of skeletal muscle small EVs independent of body mass. However, with obesity there is predominantly impaired angiogenic signalling, consistent with inadequate angiogenesis in response to basal muscle hypertrophy.